Search type: go_term
Results for query: kinase activity
| Gene Symbol | Gene Name | Links to Senescence |
|---|---|---|
| AAK1 | AP2 associated kinase 1 |
U: 1
|
| AATK | apoptosis-associated tyrosine kinase |
U: 1
|
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
U: 1
|
| ABL2 | v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
U: 2
|
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
U: 3
|
| ACSL1 | acyl-CoA synthetase long-chain family member 1 |
U: 3
D: 2
|
| ACTB | actin, beta |
U: 2
D: 2
|
| ACVR1 | activin A receptor, type 1 |
U: 1
|
| ACVR1C | activin A receptor, type IC |
U: 1
|
| ACVR2A | activin receptor IIA |
U: 1
|
| ACVR2B | activin receptor IIB |
U: 1
D: 1
|
| ADAM17 | a disintegrin and metallopeptidase domain 17 |
U: 3
D: 2
|
| ADAM8 | a disintegrin and metallopeptidase domain 8 |
D: 1
|
| ADAR | adenosine deaminase, RNA-specific |
U: 1
|
| ADCK2 | aarF domain containing kinase 2 |
U: 2
|
| ADCK5 | aarF domain containing kinase 5 |
U: 1
|
| ADIPOQ | adiponectin, C1Q and collagen domain containing |
U: 2
D: 4
|
| ADK | adenosine kinase |
D: 2
|
| ADNP | activity-dependent neuroprotective protein |
D: 1
|
| ADPGK | ADP-dependent glucokinase |
U: 1
|
| ADRA2A | adrenergic receptor, alpha 2a |
U: 2
|
| ADRB2 | adrenergic receptor, beta 2 |
U: 1
D: 1
|
| AFAP1L2 | actin filament associated protein 1 like 2 |
U: 1
D: 1
|
| AGER | advanced glycosylation end product-specific receptor |
U: 2
D: 1
|
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
U: 4
D: 1
|
| AIDA | axin interactor, dorsalization associated |
D: 1
|
| AJUBA | ajuba LIM protein |
D: 3
|
| AK1 | adenylate kinase 1 |
U: 2
D: 2
|
| AK2 | adenylate kinase 2 |
U: 1
D: 1
|
| AK3 | adenylate kinase 3 |
U: 1
D: 1
|
| AK4 | adenylate kinase 4 |
U: 1
|
| AK5 | adenylate kinase 5 |
D: 4
|
| AK6 | adenylate kinase 6 |
D: 1
|
| AKAP11 | A-kinase anchoring protein 11 |
U: 1
|
| AKAP13 | A kinase (PRKA) anchor protein 13 |
U: 1
|
| AKT1 | thymoma viral proto-oncogene 1 |
U: 21
D: 24
|
| AKT1S1 | AKT1 substrate 1 (proline-rich) |
U: 2
|
| AKT2 | thymoma viral proto-oncogene 2 |
U: 1
D: 1
|
| AKT3 | thymoma viral proto-oncogene 3 |
D: 1
|
| ALDH18A1 | aldehyde dehydrogenase 18 family, member A1 |
U: 1
|
| ALK | anaplastic lymphoma kinase |
U: 1
D: 1
|
| ALKAL2 | ALK and LTK ligand 2 | |
| ALPK1 | alpha-kinase 1 |
U: 1
|
| ALPK2 | alpha-kinase 2 |
U: 1
D: 1
|
| ALPK3 | alpha-kinase 3 |
U: 2
|
| ALS2 | alsin Rho guanine nucleotide exchange factor |
U: 1
|
| AMBRA1 | autophagy/beclin 1 regulator 1 |
D: 2
|
| ANGPT1 | angiopoietin 1 |
U: 3
D: 3
|
| ANGPT4 | angiopoietin 4 |
U: 1
|
| ANKRD54 | ankyrin repeat domain 54 |
U: 1
|
| APC | APC, WNT signaling pathway regulator |
D: 2
|
| APOE | apolipoprotein E |
U: 4
D: 2
|
| ATG13 | autophagy related 13 |
U: 1
D: 1
|
| ATG14 | autophagy related 14 |
U: 1
|
| ATM | ataxia telangiectasia mutated |
U: 28
D: 1
|
| ATP23 | ATP23 metallopeptidase and ATP synthase assembly factor homolog |
D: 1
|
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 |
U: 4
|
| ATR | ataxia telangiectasia and Rad3 related |
U: 6
D: 2
|
| AURKA | aurora kinase A |
D: 18
|
| AURKB | aurora kinase B |
D: 13
|
| AXIN1 | axin 1 |
U: 1
D: 1
|
| AXL | AXL receptor tyrosine kinase |
U: 1
D: 4
|
| AGRN | agrin |
U: 4
|
| AKAP6 | A kinase (PRKA) anchor protein 6 |
U: 1
D: 2
|
| APP | amyloid beta (A4) precursor protein |
U: 6
D: 2
|
| ARRB2 | arrestin, beta 2 |
D: 1
|
| AXIN2 | axin 2 |
U: 2
D: 1
|
| BAZ1B | bromodomain adjacent to zinc finger domain, 1B |
D: 1
|
| BCCIP | BRCA2 and CDKN1A interacting protein |
D: 1
|
| BCL10 | B cell leukemia/lymphoma 10 |
U: 1
D: 1
|
| BCR | BCR activator of RhoGEF and GTPase |
U: 1
|
| BDNF | brain derived neurotrophic factor |
U: 1
|
| BLK | B lymphoid kinase |
U: 1
|
| BLM | Bloom syndrome, RecQ like helicase |
D: 6
|
| BMP2K | BMP2 inducible kinase |
D: 1
|
| BMP4 | bone morphogenetic protein 4 |
U: 5
D: 1
|
| BMP7 | bone morphogenetic protein 7 |
U: 5
D: 3
|
| BMPR1A | bone morphogenetic protein receptor, type 1A |
D: 1
|
| BMPR1B | bone morphogenetic protein receptor, type 1B |
D: 1
|
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) |
U: 1
|
| BORA | bora, aurora kinase A activator |
D: 5
|
| BRAF | Braf transforming gene |
U: 24
D: 4
|
| BRD4 | bromodomain containing 4 |
U: 1
D: 5
|
| BRSK1 | BR serine/threonine kinase 1 |
U: 2
|
| BTK | Bruton agammaglobulinemia tyrosine kinase |
U: 4
D: 1
|
| BUB1 | BUB1, mitotic checkpoint serine/threonine kinase |
D: 9
|
| BUB1B | BUB1B, mitotic checkpoint serine/threonine kinase |
D: 9
|
| C1QTNF9 | C1q and tumor necrosis factor related protein 9 |
D: 1
|
| C5AR1 | complement component 5a receptor 1 |
U: 2
D: 1
|
| CAB39 | calcium binding protein 39 |
U: 2
D: 1
|
| CAB39L | calcium binding protein 39 like |
D: 1
|
| CACUL1 | CDK2 associated, cullin domain 1 |
U: 1
|
| CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
D: 2
|
| CALCA | calcitonin related polypeptide alpha |
D: 3
|
| CALM1 | calmodulin 1 |
U: 1
D: 1
|
| CALM3 | calmodulin 3 |
D: 2
|
| CAMK1 | calcium/calmodulin-dependent protein kinase I |
U: 1
|
| CAMK1G | calcium/calmodulin-dependent protein kinase I gamma |
U: 1
|
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha |
U: 1
D: 3
|
| CAMK2B | calcium/calmodulin-dependent protein kinase II, beta |
U: 6
|
| CAMK2D | calcium/calmodulin-dependent protein kinase II, delta |
D: 2
|
| CAMK2G | calcium/calmodulin-dependent protein kinase II gamma |
U: 2
|
| CAMK2N1 | calcium/calmodulin-dependent protein kinase II inhibitor 1 |
U: 2
D: 1
|
| CAMK2N2 | calcium/calmodulin dependent protein kinase II inhibitor 2 |
U: 1
|
| CAMK4 | calcium/calmodulin-dependent protein kinase IV |
D: 3
|
| CARD10 | caspase recruitment domain family, member 10 |
U: 1
D: 1
|
| CARD11 | caspase recruitment domain family member 11 |
D: 2
|
| CARD14 | caspase recruitment domain family member 14 |
U: 1
|
| CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
D: 1
|
| CASP3 | caspase 3 |
U: 3
D: 5
|
| CASS4 | Cas scaffolding protein family member 4 |
D: 1
|
| CAV1 | caveolin 1, caveolae protein |
U: 15
D: 7
|
| CBLC | Casitas B-lineage lymphoma c |
U: 1
D: 1
|
| CCDC88A | coiled coil domain containing 88A |
D: 2
|
| CCL2 | C-C motif chemokine ligand 2 |
U: 39
D: 6
|
| CCL3 | C-C motif chemokine ligand 3 |
U: 11
D: 1
|
| CCL5 | chemokine (C-C motif) ligand 5 |
U: 13
D: 1
|
| CCL8 | C-C motif chemokine ligand 8 |
U: 5
|
| CCN1 | cellular communication network factor 1 |
U: 4
D: 2
|
| CCNA1 | cyclin A1 |
U: 2
D: 3
|
| CCNA2 | cyclin A2 |
U: 3
D: 18
|
| CCNB1 | cyclin B1 |
D: 13
|
| CCNB2 | cyclin B2 |
D: 14
|
| CCNC | cyclin C |
D: 1
|
| CCND1 | cyclin D1 |
U: 17
D: 8
|
| CCND2 | cyclin D2 |
U: 5
D: 2
|
| CCND3 | cyclin D3 |
U: 3
|
| CCNE1 | cyclin E1 |
U: 6
D: 1
|
| CCNE2 | cyclin E2 |
U: 1
D: 3
|
| CCNF | cyclin F |
D: 3
|
| CCNG1 | cyclin G1 |
U: 3
|
| CCNG2 | cyclin G2 |
U: 1
|
| CCNH | cyclin H |
D: 2
|
| CCNI | cyclin I |
D: 2
|
| CCNJ | cyclin J |
U: 1
D: 1
|
| CCNJL | cyclin J-like |
D: 1
|
| CCNL2 | cyclin L2 |
U: 1
|
| CCNO | cyclin O |
U: 5
|
| CCNP | cyclin P | |
| CCNT1 | cyclin T1 |
U: 1
|
| CCNT2 | cyclin T2 |
D: 1
|
| CCNY | cyclin Y |
U: 1
|
| CCR7 | chemokine (C-C motif) receptor 7 |
U: 2
D: 1
|
| CD24 | CD24 molecule |
U: 2
|
| CD4 | CD4 antigen |
D: 1
|
| CD40 | CD40 antigen |
U: 1
|
| CD40LG | CD40 ligand |
U: 1
|
| CD74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
D: 4
|
| CD81 | CD81 antigen |
U: 2
D: 1
|
| CDC25A | cell division cycle 25A |
U: 2
D: 5
|
| CDC25B | cell division cycle 25B |
D: 3
|
| CDC25C | cell division cycle 25C |
D: 6
|
| CDC37 | cell division cycle 37 |
U: 2
|
| CDC42 | cell division cycle 42 |
U: 3
|
| CDC42BPA | CDC42 binding protein kinase alpha |
U: 1
D: 1
|
| CDC42BPB | CDC42 binding protein kinase beta |
U: 2
|
| CDC42BPG | CDC42 binding protein kinase gamma (DMPK-like) |
U: 3
|
| CDC6 | cell division cycle 6 |
U: 3
D: 3
|
| CDC7 | cell division cycle 7 (S. cerevisiae) |
D: 5
|
| CDK1 | cyclin-dependent kinase 1 |
U: 1
D: 11
|
| CDK11A | cyclin dependent kinase 11A |
U: 1
|
| CDK13 | cyclin-dependent kinase 13 |
U: 1
|
| CDK14 | cyclin-dependent kinase 14 |
D: 2
|
| CDK16 | cyclin-dependent kinase 16 |
U: 1
|
| CDK17 | cyclin-dependent kinase 17 |
U: 2
D: 3
|
| CDK18 | cyclin-dependent kinase 18 |
U: 3
|
| CDK2 | cyclin-dependent kinase 2 |
U: 2
D: 14
|
| CDK4 | cyclin-dependent kinase 4 |
U: 1
D: 17
|
| CDK5 | cyclin-dependent kinase 5 |
U: 3
|
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
U: 2
D: 2
|
| CDK5RAP1 | CDK5 regulatory subunit associated protein 1 |
U: 1
|
| CDK5RAP3 | CDK5 regulatory subunit associated protein 3 |
U: 1
D: 1
|
| CDK6 | cyclin-dependent kinase 6 |
U: 1
D: 9
|
| CDK7 | cyclin-dependent kinase 7 |
U: 1
D: 1
|
| CDK9 | cyclin-dependent kinase 9 (CDC2-related kinase) |
U: 1
D: 1
|
| CDKL1 | cyclin-dependent kinase-like 1 (CDC2-related kinase) |
D: 1
|
| CDKL2 | cyclin-dependent kinase-like 2 (CDC2-related kinase) |
U: 1
|
| CDKL5 | cyclin-dependent kinase-like 5 |
D: 2
|
| CDKN1A | cyclin-dependent kinase inhibitor 1A (P21) |
U: 209
D: 24
|
| CDKN1B | cyclin-dependent kinase inhibitor 1B |
U: 22
D: 4
|
| CDKN1C | cyclin-dependent kinase inhibitor 1C (P57) |
U: 5
D: 3
|
| CDKN2A | cyclin dependent kinase inhibitor 2A |
U: 238
D: 5
|
| CDKN2B | cyclin dependent kinase inhibitor 2B |
U: 16
D: 3
|
| CDKN2C | cyclin dependent kinase inhibitor 2C |
U: 2
D: 3
|
| CDKN2D | cyclin dependent kinase inhibitor 2D |
U: 5
D: 1
|
| CDKN3 | cyclin dependent kinase inhibitor 3 |
D: 6
|
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 |
U: 2
|
| CEBPA | CCAAT enhancer binding protein alpha |
U: 4
D: 1
|
| CENPE | centromere protein E |
D: 6
|
| CEP43 | centrosomal protein 43 | |
| CEP85 | centrosomal protein 85 |
D: 2
|
| CERK | ceramide kinase |
D: 2
|
| CERKL | ceramide kinase-like |
U: 1
|
| CERT1 | ceramide transporter 1 | |
| CHEK1 | checkpoint kinase 1 |
U: 3
D: 9
|
| CHEK2 | checkpoint kinase 2 |
U: 9
D: 5
|
| CHI3L1 | chitinase 3 like 1 |
U: 4
|
| CHKA | choline kinase alpha |
U: 1
D: 1
|
| CHKB | choline kinase beta |
U: 2
D: 1
|
| CHORDC1 | cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein 1 |
D: 1
|
| CHP1 | calcineurin-like EF hand protein 1 |
U: 1
|
| CHRNA3 | cholinergic receptor, nicotinic, alpha polypeptide 3 |
U: 1
|
| CHUK | conserved helix-loop-helix ubiquitous kinase |
U: 2
D: 2
|
| CIB1 | calcium and integrin binding 1 (calmyrin) |
D: 1
|
| CIITA | class II transactivator |
D: 1
|
| CISH | cytokine inducible SH2 containing protein |
D: 2
|
| CIT | citron |
D: 5
|
| CKB | creatine kinase, brain |
U: 3
D: 2
|
| CKM | creatine kinase, muscle |
U: 2
D: 1
|
| CKMT1B | creatine kinase, mitochondrial 1B |
U: 1
|
| CKS1B | CDC28 protein kinase 1b |
D: 6
|
| CKS2 | CDC28 protein kinase regulatory subunit 2 |
D: 6
|
| CLK1 | CDC-like kinase 1 |
U: 1
|
| CLK2 | CDC-like kinase 2 |
D: 1
|
| CLK4 | CDC like kinase 4 |
U: 1
|
| CLSPN | claspin |
D: 2
|
| CLU | clusterin |
U: 3
D: 5
|
| CMPK1 | cytidine monophosphate (UMP-CMP) kinase 1 |
U: 2
|
| CMPK2 | cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
U: 2
|
| CNPPD1 | cyclin Pas1/PHO80 domain containing 1 |
U: 1
|
| COPS8 | COP9 signalosome subunit 8 |
U: 1
|
| COQ8A | coenzyme Q8A |
U: 1
|
| CORO1C | coronin, actin binding protein 1C |
U: 1
|
| CPNE3 | copine III |
U: 1
|
| CSF1 | colony stimulating factor 1 (macrophage) |
U: 5
|
| CSF1R | colony stimulating factor 1 receptor |
U: 1
D: 2
|
| CSNK1A1 | casein kinase 1, alpha 1 |
U: 2
D: 2
|
| CSNK1D | casein kinase 1, delta |
U: 1
|
| CSNK1E | casein kinase 1, epsilon |
U: 1
|
| CSNK1G1 | casein kinase 1, gamma 1 |
U: 1
|
| CSNK2A1 | casein kinase 2, alpha 1 polypeptide |
U: 5
D: 5
|
| CSNK2B | casein kinase 2, beta polypeptide |
U: 1
|
| CXCL10 | C-X-C motif chemokine ligand 10 |
U: 11
|
| CBS | cystathionine beta-synthase |
U: 2
D: 4
|
| DAB1 | disabled 1 |
D: 2
|
| DAB2IP | disabled 2 interacting protein |
U: 1
D: 1
|
| DAG1 | dystroglycan 1 |
U: 1
D: 1
|
| DAPK1 | death associated protein kinase 1 |
U: 2
D: 1
|
| DAPK2 | death-associated protein kinase 2 |
U: 3
|
| DAPK3 | death-associated protein kinase 3 |
U: 2
|
| DAXX | Fas death domain-associated protein |
D: 1
|
| DBF4 | DBF4 zinc finger |
D: 3
|
| DBF4B | DBF4 zinc finger B |
D: 4
|
| DBNDD1 | dysbindin (dystrobrevin binding protein 1) domain containing 1 |
U: 1
|
| DBNDD2 | dysbindin (dystrobrevin binding protein 1) domain containing 2 |
U: 1
|
| DBNL | drebrin like |
D: 2
|
| DCAF1 | DDB1 and CUL4 associated factor 1 |
D: 1
|
| DCAKD | dephospho-CoA kinase domain containing |
U: 2
|
| DCK | deoxycytidine kinase |
D: 1
|
| DCLK1 | doublecortin-like kinase 1 |
U: 3
D: 1
|
| DCLK2 | doublecortin-like kinase 2 |
U: 1
D: 1
|
| DCLK3 | doublecortin-like kinase 3 |
U: 1
|
| DDR1 | discoidin domain receptor family, member 1 |
U: 1
|
| DDR2 | discoidin domain receptor family, member 2 |
U: 3
D: 1
|
| DEPTOR | DEP domain containing MTOR-interacting protein |
U: 1
D: 1
|
| DGKA | diacylglycerol kinase, alpha |
U: 2
|
| DGKB | diacylglycerol kinase, beta |
D: 1
|
| DGKD | diacylglycerol kinase, delta |
U: 1
|
| DGKE | diacylglycerol kinase, epsilon |
U: 1
|
| DGKG | diacylglycerol kinase, gamma |
U: 1
|
| DGKH | diacylglycerol kinase, eta |
U: 2
|
| DGKQ | diacylglycerol kinase, theta |
U: 2
|
| DGKZ | diacylglycerol kinase zeta |
U: 2
D: 1
|
| DGUOK | deoxyguanosine kinase |
D: 1
|
| DIRAS1 | DIRAS family GTPase 1 |
U: 1
D: 1
|
| DIRAS2 | DIRAS family GTPase 2 |
U: 1
|
| DIRAS3 | DIRAS family GTPase 3 |
D: 1
|
| DKK1 | dickkopf WNT signaling pathway inhibitor 1 |
U: 7
D: 2
|
| DLG1 | discs large MAGUK scaffold protein 1 |
U: 1
|
| DLG2 | discs large MAGUK scaffold protein 2 |
U: 1
|
| DLG3 | discs large MAGUK scaffold protein 3 |
D: 3
|
| DLG4 | discs large MAGUK scaffold protein 4 |
U: 1
D: 2
|
| DMPK | dystrophia myotonica-protein kinase |
U: 2
|
| DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 |
U: 1
D: 2
|
| DNAJC3 | DnaJ heat shock protein family (Hsp40) member C3 |
U: 1
D: 1
|
| DOCK3 | dedicator of cytokinesis 3 |
U: 1
|
| DOK7 | docking protein 7 |
U: 1
D: 1
|
| DRD2 | dopamine receptor D2 |
U: 1
|
| DRD4 | dopamine receptor D4 |
U: 1
|
| DTNBP1 | dystrobrevin binding protein 1 |
D: 2
|
| DTYMK | deoxythymidylate kinase |
D: 2
|
| DUSP1 | dual specificity phosphatase 1 |
U: 4
D: 5
|
| DUSP10 | dual specificity phosphatase 10 |
U: 2
D: 1
|
| DUSP12 | dual specificity phosphatase 12 |
D: 1
|
| DUSP16 | dual specificity phosphatase 16 |
D: 2
|
| DUSP2 | dual specificity phosphatase 2 |
U: 2
|
| DUSP26 | dual specificity phosphatase 26 (putative) |
U: 2
|
| DUSP3 | dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related) |
U: 2
D: 1
|
| DUSP4 | dual specificity phosphatase 4 |
U: 2
D: 2
|
| DUSP5 | dual specificity phosphatase 5 |
U: 3
D: 1
|
| DUSP7 | dual specificity phosphatase 7 |
D: 2
|
| DUSP8 | dual specificity phosphatase 8 |
U: 1
|
| DVL2 | dishevelled segment polarity protein 2 |
D: 1
|
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
D: 1
|
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
U: 2
|
| DYRK3 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
U: 1
|
| DYRK4 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 |
U: 1
D: 1
|
| DAB2 | disabled 2, mitogen-responsive phosphoprotein |
U: 2
D: 2
|
| DRD1 | dopamine receptor D1 |
D: 2
|
| ECT2 | ect2 oncogene |
D: 3
|
| EDN1 | endothelin 1 |
U: 5
D: 1
|
| EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 |
D: 2
|
| EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 |
U: 2
D: 1
|
| EEF2K | eukaryotic elongation factor-2 kinase |
D: 1
|
| EFNA1 | ephrin A1 |
U: 2
|
| EFNA5 | ephrin A5 |
U: 2
D: 2
|
| EGF | epidermal growth factor |
U: 4
D: 5
|
| EGFR | epidermal growth factor receptor |
U: 2
D: 11
|
| EGR1 | early growth response 1 |
U: 4
D: 5
|
| EIF2AK1 | eukaryotic translation initiation factor 2 alpha kinase 1 |
U: 1
|
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 |
U: 2
|
| EIF2AK3 | eukaryotic translation initiation factor 2 alpha kinase 3 |
U: 2
D: 1
|
| EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 |
U: 1
|
| ELANE | elastase, neutrophil expressed |
U: 1
D: 1
|
| ELP3 | elongator acetyltransferase complex subunit 3 |
U: 1
|
| ELP4 | elongator acetyltransferase complex subunit 4 |
D: 3
|
| EMP2 | epithelial membrane protein 2 |
U: 3
D: 2
|
| EPGN | epithelial mitogen |
U: 1
D: 1
|
| EPHA2 | Eph receptor A2 |
U: 2
D: 2
|
| EPHA3 | Eph receptor A3 |
D: 2
|
| EPHA4 | Eph receptor A4 |
U: 1
D: 1
|
| EPHA6 | Eph receptor A6 |
U: 1
|
| EPHA7 | Eph receptor A7 |
D: 2
|
| EPHB1 | Eph receptor B1 |
D: 3
|
| EPHB2 | Eph receptor B2 |
U: 2
D: 3
|
| EPHB3 | Eph receptor B3 |
U: 2
D: 2
|
| EPHB4 | Eph receptor B4 |
U: 1
D: 1
|
| EPHB6 | Eph receptor B6 |
D: 1
|
| ERBB2 | erb-b2 receptor tyrosine kinase 2 |
U: 9
|
| ERBB3 | erb-b2 receptor tyrosine kinase 3 |
U: 1
D: 1
|
| ERBB4 | erb-b2 receptor tyrosine kinase 4 |
U: 2
D: 1
|
| ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 |
U: 1
|
| EREG | epiregulin |
U: 3
D: 3
|
| ERN1 | endoplasmic reticulum (ER) to nucleus signalling 1 |
U: 3
D: 2
|
| ETAA1 | Ewing tumor-associated antigen 1 |
D: 2
|
| ETNK1 | ethanolamine kinase 1 |
U: 3
|
| EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
U: 1
D: 26
|
| EDNRA | endothelin receptor type A |
D: 5
|
| ELP1 | elongator complex protein 1 |
U: 1
D: 2
|
| EPM2A | epilepsy, progressive myoclonic epilepsy, type 2 gene alpha |
U: 1
|
| F2 | coagulation factor II, thrombin |
U: 2
|
| FABP4 | fatty acid binding protein 4, adipocyte |
D: 4
|
| FAF1 | Fas associated factor 1 |
D: 1
|
| FASTK | Fas-activated serine/threonine kinase |
U: 1
|
| FCGR1A | Fc fragment of IgG receptor Ia |
U: 2
|
| FER | fer (fms/fps related) protein kinase |
D: 2
|
| FGF1 | fibroblast growth factor 1 |
U: 3
D: 2
|
| FGF18 | fibroblast growth factor 18 |
U: 3
|
| FGF2 | fibroblast growth factor 2 |
U: 14
D: 6
|
| FGFR1 | fibroblast growth factor receptor 1 |
U: 2
|
| FGFR2 | fibroblast growth factor receptor 2 |
U: 3
D: 1
|
| FGFR3 | fibroblast growth factor receptor 3 |
U: 3
D: 1
|
| FGFR4 | fibroblast growth factor receptor 4 |
D: 3
|
| FLT1 | FMS-like tyrosine kinase 1 |
U: 4
D: 4
|
| FLT4 | FMS-like tyrosine kinase 4 |
U: 1
|
| FN3K | fructosamine 3 kinase |
U: 2
|
| FOXA2 | forkhead box A2 |
D: 1
|
| FRK | fyn-related kinase |
D: 1
|
| FYN | Fyn proto-oncogene |
D: 2
|
| FZD4 | frizzled class receptor 4 |
D: 2
|
| FZD5 | frizzled class receptor 5 |
U: 2
D: 1
|
| FZD8 | frizzled class receptor 8 |
U: 2
D: 2
|
| FGD4 | FYVE, RhoGEF and PH domain containing 4 |
U: 2
|
| GADD45A | growth arrest and DNA-damage-inducible 45 alpha |
U: 7
D: 1
|
| GADD45B | growth arrest and DNA-damage-inducible 45 beta |
U: 5
D: 2
|
| GAK | cyclin G associated kinase |
U: 1
D: 1
|
| GALK1 | galactokinase 1 |
D: 1
|
| GALK2 | galactokinase 2 |
D: 1
|
| GAS6 | growth arrest specific 6 |
U: 3
D: 4
|
| GBA | glucosidase, beta, acid |
U: 3
D: 1
|
| GCG | glucagon |
D: 1
|
| GCK | glucokinase |
U: 1
D: 2
|
| GCKR | glucokinase regulatory protein |
U: 1
|
| GH1 | growth hormone 1 |
U: 2
|
| GHR | growth hormone receptor |
U: 3
|
| GK | glycerol kinase |
D: 1
|
| GK5 | glycerol kinase 5 (putative) |
U: 2
|
| GLYCTK | glycerate kinase |
D: 2
|
| GMFB | glia maturation factor beta |
D: 1
|
| GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
D: 1
|
| GPRC5A | G protein-coupled receptor class C group 5 member A |
U: 4
|
| GPRC5B | G protein-coupled receptor, family C, group 5, member B |
U: 1
D: 1
|
| GPRC5C | G protein-coupled receptor class C group 5 member C |
U: 1
D: 2
|
| GRK3 | G protein-coupled receptor kinase 3 |
D: 1
|
| GRK4 | G protein-coupled receptor kinase 4 |
U: 3
|
| GRK6 | G protein-coupled receptor kinase 6 |
U: 1
D: 2
|
| GSK3B | glycogen synthase kinase 3 beta |
U: 1
D: 6
|
| GSKIP | GSK3B interacting protein |
D: 1
|
| GSTP1 | glutathione S-transferase, pi 1 |
U: 1
|
| GTF2H1 | general transcription factor II H, polypeptide 1 |
U: 1
|
| GTF2H3 | general transcription factor IIH, polypeptide 3 |
D: 1
|
| GTPBP4 | GTP binding protein 4 |
U: 1
D: 3
|
| GUCY2C | guanylate cyclase 2c |
U: 1
|
| GUK1 | guanylate kinase 1 |
U: 1
|
| GAB1 | growth factor receptor bound protein 2-associated protein 1 |
D: 2
|
| GADD45G | growth arrest and DNA-damage-inducible 45 gamma |
U: 4
D: 1
|
| HACD3 | 3-hydroxyacyl-CoA dehydratase 3 | |
| HASPIN | histone H3 associated protein kinase |
D: 3
|
| HEG1 | heart development protein with EGF-like domains 1 |
U: 3
|
| HERC5 | HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
U: 4
|
| HEXIM1 | hexamethylene bis-acetamide inducible 1 |
U: 1
|
| HGF | hepatocyte growth factor |
U: 4
D: 2
|
| HGS | HGF-regulated tyrosine kinase substrate |
U: 1
|
| HHEX | hematopoietically expressed homeobox |
U: 3
D: 2
|
| HIPK1 | homeodomain interacting protein kinase 1 |
U: 1
|
| HIPK2 | homeodomain interacting protein kinase 2 |
U: 2
|
| HIPK3 | homeodomain interacting protein kinase 3 |
U: 2
|
| HK1 | hexokinase 1 |
U: 1
|
| HK2 | hexokinase 2 |
U: 1
D: 3
|
| HKDC1 | hexokinase domain containing 1 |
U: 3
|
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
U: 2
D: 2
|
| HMGA2 | high mobility group AT-hook 2 |
U: 3
D: 2
|
| HMGCR | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
U: 2
D: 2
|
| HNRNPU | heterogeneous nuclear ribonucleoprotein U |
U: 1
D: 2
|
| HRAS | Harvey rat sarcoma virus oncogene |
U: 32
|
| HSP90AA1 | heat shock protein 90, alpha (cytosolic), class A member 1 |
U: 3
D: 4
|
| HSP90AB1 | heat shock protein 90 alpha (cytosolic), class B member 1 |
U: 1
D: 2
|
| HSPB1 | heat shock protein 1 |
U: 4
D: 3
|
| HSPB8 | heat shock protein family B (small) member 8 |
U: 4
D: 1
|
| HTATIP2 | HIV-1 Tat interactive protein 2 |
U: 1
|
| HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A |
U: 2
|
| HUNK | hormonally upregulated Neu-associated kinase |
U: 1
D: 2
|
| HYAL2 | hyaluronoglucosaminidase 2 |
U: 2
|
| HYKK | hydroxylysine kinase 1 |
D: 1
|
| HNF4A | hepatic nuclear factor 4, alpha |
U: 2
|
| HSPH1 | heat shock 105kDa/110kDa protein 1 |
U: 2
|
| IBTK | inhibitor of Bruton tyrosine kinase |
D: 1
|
| IDNK | idnK gluconokinase homolog (E. coli) |
U: 2
|
| IFNG | interferon gamma |
U: 13
|
| IGF1R | insulin-like growth factor I receptor |
U: 9
D: 4
|
| IGF2 | insulin like growth factor 2 |
U: 3
D: 2
|
| IKBKB | inhibitor of kappaB kinase beta |
U: 2
D: 1
|
| IKBKE | inhibitor of kappaB kinase epsilon |
U: 1
|
| IL1B | interleukin 1 beta |
U: 48
D: 9
|
| IL2 | interleukin 2 |
U: 3
D: 2
|
| IL23A | interleukin 23, alpha subunit p19 |
U: 5
D: 1
|
| IL23R | interleukin 23 receptor |
U: 1
|
| IL34 | interleukin 34 |
U: 2
D: 1
|
| IL4 | interleukin 4 |
U: 4
|
| IL6R | interleukin 6 receptor |
U: 2
D: 1
|
| ILK | integrin linked kinase |
U: 2
D: 1
|
| INCENP | inner centromere protein |
D: 4
|
| INKA2 | inka box actin regulator 2 | |
| INPP5K | inositol polyphosphate 5-phosphatase K |
U: 1
|
| INSR | insulin receptor |
U: 2
D: 2
|
| IP6K2 | inositol hexaphosphate kinase 2 |
U: 1
|
| IP6K3 | inositol hexaphosphate kinase 3 |
U: 2
D: 1
|
| IPO5 | importin 5 |
D: 1
|
| IPO7 | importin 7 |
D: 1
|
| IQGAP1 | IQ motif containing GTPase activating protein 1 |
U: 2
D: 2
|
| IRAK1 | interleukin-1 receptor-associated kinase 1 |
U: 2
D: 3
|
| IRAK2 | interleukin-1 receptor-associated kinase 2 |
U: 2
D: 2
|
| IRAK4 | interleukin-1 receptor-associated kinase 4 |
U: 1
|
| IRS1 | insulin receptor substrate 1 |
U: 2
D: 3
|
| IRS2 | insulin receptor substrate 2 |
U: 1
|
| ITGB3 | integrin beta 3 |
U: 5
D: 2
|
| ITK | IL2 inducible T cell kinase |
U: 1
|
| ITPK1 | inositol 1,3,4-triphosphate 5/6 kinase |
U: 1
D: 1
|
| ITPKA | inositol 1,4,5-trisphosphate 3-kinase A |
U: 2
D: 1
|
| ITPKB | inositol 1,4,5-trisphosphate 3-kinase B |
U: 2
D: 1
|
| ITPKC | inositol 1,4,5-trisphosphate 3-kinase C |
U: 1
|
| ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein |
D: 1
|
| ITSN1 | intersectin 1 |
D: 2
|
| IGF1 | insulin-like growth factor 1 |
U: 12
D: 7
|
| IKBKG | inhibitor of kappaB kinase gamma |
D: 1
|
| IL1RN | interleukin 1 receptor antagonist |
U: 4
D: 1
|
| IL3 | interleukin 3 |
U: 1
|
| IL6 | interleukin 6 |
U: 97
D: 20
|
| INPPL1 | inositol polyphosphate phosphatase-like 1 |
U: 3
|
| JAK1 | Janus kinase 1 |
U: 3
D: 1
|
| JAK2 | Janus kinase 2 |
U: 3
|
| JAK3 | Janus kinase 3 |
U: 2
|
| KALRN | kalirin, RhoGEF kinase |
U: 1
D: 1
|
| KAT2B | K(lysine) acetyltransferase 2B |
U: 4
D: 1
|
| KDR | kinase insert domain protein receptor |
U: 2
D: 5
|
| KHK | ketohexokinase |
U: 1
D: 2
|
| KIF14 | kinesin family member 14 |
D: 5
|
| KIT | KIT proto-oncogene receptor tyrosine kinase |
U: 1
D: 2
|
| KITLG | KIT ligand |
D: 3
|
| KLF4 | Kruppel like factor 4 |
U: 3
D: 7
|
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
U: 18
D: 3
|
| KSR1 | kinase suppressor of ras 1 |
D: 3
|
| KSR2 | kinase suppressor of ras 2 |
D: 1
|
| LATS1 | large tumor suppressor |
D: 2
|
| LATS2 | large tumor suppressor 2 |
U: 2
D: 2
|
| LCK | lymphocyte protein tyrosine kinase |
U: 1
|
| LDB1 | LIM domain binding 1 |
U: 1
|
| LDB2 | LIM domain binding 2 |
D: 5
|
| LIMK1 | LIM-domain containing, protein kinase |
U: 3
D: 1
|
| LIMK2 | LIM motif-containing protein kinase 2 |
U: 2
|
| LMO4 | LIM domain only 4 |
U: 2
|
| LMTK2 | lemur tyrosine kinase 2 |
U: 1
|
| LMTK3 | lemur tyrosine kinase 3 |
U: 2
|
| LRP5 | low density lipoprotein receptor-related protein 5 |
U: 2
D: 1
|
| LRP6 | low density lipoprotein receptor-related protein 6 |
D: 1
|
| LRP8 | low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
D: 2
|
| LRRK1 | leucine-rich repeat kinase 1 |
U: 1
|
| LRRK2 | leucine-rich repeat kinase 2 |
U: 1
|
| LTF | lactotransferrin |
U: 1
D: 1
|
| LYN | LYN proto-oncogene, Src family tyrosine kinase |
D: 1
|
| MACROH2A1 | macroH2A.1 histone | |
| MAGED1 | melanoma antigen, family D, 1 |
U: 1
D: 1
|
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 |
D: 3
|
| MALT1 | MALT1 paracaspase |
D: 2
|
| MAP2K1 | mitogen-activated protein kinase kinase 1 |
U: 3
|
| MAP2K2 | mitogen-activated protein kinase kinase 2 |
U: 5
D: 1
|
| MAP2K3 | mitogen-activated protein kinase kinase 3 |
U: 5
D: 1
|
| MAP2K4 | mitogen-activated protein kinase kinase 4 |
U: 2
|
| MAP2K6 | mitogen-activated protein kinase kinase 6 |
U: 1
D: 4
|
| MAP2K7 | mitogen-activated protein kinase kinase 7 |
D: 3
|
| MAP3K10 | mitogen-activated protein kinase kinase kinase 10 |
U: 1
|
| MAP3K11 | mitogen-activated protein kinase kinase kinase 11 |
U: 1
|
| MAP3K12 | mitogen-activated protein kinase kinase kinase 12 |
U: 1
|
| MAP3K13 | mitogen-activated protein kinase kinase kinase 13 |
D: 1
|
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 |
U: 1
D: 3
|
| MAP3K15 | mitogen-activated protein kinase kinase kinase 15 |
U: 1
|
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 |
U: 1
|
| MAP3K20 | mitogen-activated protein kinase kinase kinase 20 |
D: 3
|
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 |
U: 1
D: 2
|
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
U: 1
D: 1
|
| MAP3K6 | mitogen-activated protein kinase kinase kinase 6 |
U: 4
D: 1
|
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
U: 2
|
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 |
U: 1
|
| MAP3K9 | mitogen-activated protein kinase kinase kinase 9 |
U: 4
D: 2
|
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 |
U: 1
D: 3
|
| MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 |
U: 1
|
| MAP4K3 | mitogen-activated protein kinase kinase kinase kinase 3 |
D: 1
|
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 |
U: 2
|
| MAPK1 | mitogen-activated protein kinase 1 |
U: 17
D: 6
|
| MAPK10 | mitogen-activated protein kinase 10 |
U: 1
D: 2
|
| MAPK11 | mitogen-activated protein kinase 11 |
U: 4
|
| MAPK12 | mitogen-activated protein kinase 12 |
U: 2
D: 1
|
| MAPK13 | mitogen-activated protein kinase 13 |
U: 2
D: 2
|
| MAPK14 | mitogen-activated protein kinase 14 |
U: 44
D: 6
|
| MAPK15 | mitogen-activated protein kinase 15 |
D: 1
|
| MAPK3 | mitogen-activated protein kinase 3 |
U: 10
D: 4
|
| MAPK4 | mitogen-activated protein kinase 4 |
U: 1
D: 1
|
| MAPK6 | mitogen-activated protein kinase 6 |
U: 1
|
| MAPK7 | mitogen-activated protein kinase 7 |
D: 1
|
| MAPK8 | mitogen-activated protein kinase 8 |
U: 5
D: 3
|
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 |
U: 1
D: 1
|
| MAPK8IP3 | mitogen-activated protein kinase 8 interacting protein 3 |
U: 1
|
| MAPK9 | mitogen-activated protein kinase 9 |
U: 1
D: 3
|
| MAPKAPK2 | MAP kinase-activated protein kinase 2 |
U: 2
D: 1
|
| MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 |
U: 1
|
| MAPKAPK5 | MAP kinase-activated protein kinase 5 |
U: 2
|
| MAPRE3 | microtubule-associated protein, RP/EB family, member 3 |
U: 2
|
| MAPT | microtubule-associated protein tau |
U: 1
D: 1
|
| MARK2 | MAP/microtubule affinity regulating kinase 2 |
U: 1
|
| MARK3 | MAP/microtubule affinity regulating kinase 3 |
D: 1
|
| MARK4 | MAP/microtubule affinity regulating kinase 4 |
U: 1
|
| MAST1 | microtubule associated serine/threonine kinase 1 |
U: 3
|
| MAST3 | microtubule associated serine/threonine kinase 3 |
U: 1
|
| MAST4 | microtubule associated serine/threonine kinase family member 4 |
U: 2
|
| MASTL | microtubule associated serine/threonine kinase-like |
D: 3
|
| MATK | megakaryocyte-associated tyrosine kinase |
U: 1
|
| MDFIC | MyoD family inhibitor domain containing |
D: 1
|
| MELK | maternal embryonic leucine zipper kinase |
D: 4
|
| MEN1 | multiple endocrine neoplasia 1 |
U: 1
D: 1
|
| MERTK | MER proto-oncogene tyrosine kinase |
U: 2
|
| MET | met proto-oncogene |
U: 1
D: 1
|
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
U: 3
D: 5
|
| MINK1 | misshapen-like kinase 1 (zebrafish) |
U: 2
|
| MIR125B1 | microRNA 125b-1 |
U: 1
D: 1
|
| MIR138-1 | microRNA 138-1 |
U: 1
|
| MIR20A | microRNA 20a | |
| MIR24-1 | microRNA 24-1 |
U: 1
|
| MIR24-2 | microRNA 24-2 | |
| MIR711 | microRNA 711 |
U: 1
|
| MKNK1 | MAP kinase-interacting serine/threonine kinase 1 |
U: 2
|
| MKNK2 | MAP kinase-interacting serine/threonine kinase 2 |
U: 1
|
| MLKL | mixed lineage kinase domain-like |
D: 1
|
| MLLT1 | myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 |
U: 1
D: 1
|
| MMD | monocyte to macrophage differentiation-associated |
U: 3
|
| MOB1B | MOB kinase activator 1B |
U: 1
|
| MOK | MOK protein kinase |
D: 1
|
| MOS | Moloney sarcoma oncogene |
U: 2
|
| MRNIP | MRN complex interacting protein |
U: 1
|
| MST1 | macrophage stimulating 1 (hepatocyte growth factor-like) |
U: 1
D: 1
|
| MSTN | myostatin |
D: 1
|
| MTOR | mechanistic target of rapamycin kinase |
U: 36
D: 10
|
| MUL1 | mitochondrial ubiquitin ligase activator of NFKB 1 |
U: 1
|
| MUSK | muscle, skeletal, receptor tyrosine kinase |
D: 1
|
| MVK | mevalonate kinase |
U: 4
D: 1
|
| MVP | major vault protein |
U: 4
|
| MYLK | myosin, light polypeptide kinase |
U: 3
D: 2
|
| MYLK2 | myosin, light polypeptide kinase 2, skeletal muscle |
D: 2
|
| MYLK3 | myosin light chain kinase 3 |
U: 1
D: 1
|
| MYLK4 | myosin light chain kinase family, member 4 |
U: 1
|
| MYOCD | myocardin |
U: 1
D: 1
|
| MDFI | MyoD family inhibitor |
D: 1
|
| MPP6 | membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
D: 1
|
| MRE11A | MRE11A homolog A, double strand break repair nuclease |
D: 1
|
| N4BP2 | NEDD4 binding protein 2 |
D: 2
|
| NADK | NAD kinase |
U: 2
|
| NADK2 | NAD kinase 2, mitochondrial |
D: 2
|
| NAGK | N-acetylglucosamine kinase |
U: 3
|
| NAGS | N-acetylglutamate synthase |
D: 1
|
| NBN | nibrin |
U: 2
D: 2
|
| NCAPG2 | non-SMC condensin II complex, subunit G2 |
D: 5
|
| NCKAP1L | NCK associated protein 1 like |
U: 1
D: 1
|
| NEDD9 | neural precursor cell expressed, developmentally down-regulated gene 9 |
U: 1
D: 4
|
| NEK1 | NIMA (never in mitosis gene a)-related expressed kinase 1 |
U: 1
D: 1
|
| NEK10 | NIMA (never in mitosis gene a)- related kinase 10 |
U: 2
|
| NEK2 | NIMA (never in mitosis gene a)-related expressed kinase 2 |
D: 6
|
| NEK3 | NIMA (never in mitosis gene a)-related expressed kinase 3 |
D: 1
|
| NEK4 | NIMA (never in mitosis gene a)-related expressed kinase 4 |
U: 1
D: 1
|
| NEK6 | NIMA (never in mitosis gene a)-related expressed kinase 6 |
U: 2
D: 4
|
| NEK7 | NIMA (never in mitosis gene a)-related expressed kinase 7 |
U: 1
D: 1
|
| NEK9 | NIMA (never in mitosis gene a)-related expressed kinase 9 |
D: 1
|
| NF1 | neurofibromin 1 |
U: 2
D: 2
|
| NF2 | neurofibromin 2 |
U: 1
|
| NHLRC1 | NHL repeat containing 1 |
U: 1
|
| NLK | nemo like kinase |
U: 1
|
| NLRC5 | NLR family, CARD domain containing 5 |
U: 3
|
| NME1 | NME/NM23 nucleoside diphosphate kinase 1 |
U: 1
D: 1
|
| NME2 | NME/NM23 nucleoside diphosphate kinase 2 |
U: 1
D: 1
|
| NME3 | NME/NM23 nucleoside diphosphate kinase 3 |
U: 2
|
| NME6 | NME/NM23 nucleoside diphosphate kinase 6 |
D: 1
|
| NME7 | NME/NM23 family member 7 |
D: 1
|
| NME9 | NME/NM23 family member 9 |
U: 1
|
| NMRK1 | nicotinamide riboside kinase 1 |
U: 3
|
| NOD2 | nucleotide-binding oligomerization domain containing 2 |
U: 1
D: 1
|
| NOL9 | nucleolar protein 9 |
U: 1
D: 1
|
| NOX4 | NADPH oxidase 4 |
U: 18
D: 2
|
| NPFFR2 | neuropeptide FF receptor 2 |
U: 1
|
| NPM1 | nucleophosmin 1 |
U: 3
D: 2
|
| NPPA | natriuretic peptide type A |
U: 3
|
| NPRL2 | NPR2 like, GATOR1 complex subunit |
U: 1
|
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 |
U: 1
|
| NRBF2 | nuclear receptor binding factor 2 |
U: 1
D: 1
|
| NRBP1 | nuclear receptor binding protein 1 |
U: 1
D: 1
|
| NRBP2 | nuclear receptor binding protein 2 |
U: 3
|
| NRG1 | neuregulin 1 |
U: 2
D: 3
|
| NRG3 | neuregulin 3 |
D: 1
|
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 |
U: 2
|
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 |
U: 2
|
| NUAK1 | NUAK family, SNF1-like kinase, 1 |
U: 2
D: 1
|
| NUAK2 | NUAK family, SNF1-like kinase, 2 |
U: 1
|
| OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
U: 1
D: 2
|
| OXSR1 | oxidative-stress responsive 1 |
U: 2
D: 1
|
| P2RY12 | purinergic receptor P2Y12 |
U: 1
|
| PAK1 | p21 (RAC1) activated kinase 1 |
D: 1
|
| PAK2 | p21 (RAC1) activated kinase 2 |
U: 2
|
| PAK3 | p21 (RAC1) activated kinase 3 |
D: 1
|
| PAK4 | p21 (RAC1) activated kinase 4 |
U: 1
D: 2
|
| PAK6 | p21 (RAC1) activated kinase 6 |
U: 2
|
| PANK1 | pantothenate kinase 1 |
U: 1
D: 1
|
| PANK2 | pantothenate kinase 2 |
U: 1
D: 1
|
| PANK3 | pantothenate kinase 3 |
D: 1
|
| PANK4 | pantothenate kinase 4 |
U: 1
|
| PAPSS1 | 3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
U: 2
|
| PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
U: 1
D: 1
|
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 |
U: 1
D: 2
|
| PARP16 | poly (ADP-ribose) polymerase family, member 16 |
U: 1
|
| PARP8 | poly(ADP-ribose) polymerase family member 8 |
U: 1
|
| PASK | PAS domain containing serine/threonine kinase |
D: 1
|
| PBK | PDZ binding kinase |
D: 6
|
| PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
U: 2
D: 2
|
| PDCD10 | programmed cell death 10 |
U: 2
|
| PDCD4 | programmed cell death 4 |
U: 2
D: 1
|
| PDE5A | phosphodiesterase 5A, cGMP-specific |
U: 1
D: 1
|
| PDGFA | platelet derived growth factor, alpha |
U: 3
|
| PDGFB | platelet derived growth factor, B polypeptide |
U: 4
D: 2
|
| PDGFC | platelet-derived growth factor, C polypeptide |
U: 3
|
| PDGFD | platelet-derived growth factor, D polypeptide |
D: 1
|
| PDGFRA | platelet derived growth factor receptor, alpha polypeptide |
U: 2
D: 2
|
| PDGFRB | platelet derived growth factor receptor, beta polypeptide |
D: 4
|
| PDIK1L | PDLIM1 interacting kinase 1 like |
U: 2
D: 1
|
| PDK1 | pyruvate dehydrogenase kinase, isoenzyme 1 |
D: 2
|
| PDK2 | pyruvate dehydrogenase kinase, isoenzyme 2 |
U: 2
|
| PDK3 | pyruvate dehydrogenase kinase, isoenzyme 3 |
U: 1
|
| PDK4 | pyruvate dehydrogenase kinase, isoenzyme 4 |
U: 2
D: 3
|
| PDPK1 | 3-phosphoinositide dependent protein kinase 1 |
U: 2
|
| PDXK | pyridoxal (pyridoxine, vitamin B6) kinase |
U: 3
|
| PEAK1 | pseudopodium-enriched atypical kinase 1 |
D: 1
|
| PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
U: 1
|
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
U: 1
D: 1
|
| PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
U: 1
|
| PFKM | phosphofructokinase, muscle |
U: 1
D: 1
|
| PFKP | phosphofructokinase, platelet |
U: 1
|
| PGK1 | phosphoglycerate kinase 1 |
U: 1
|
| PHKA2 | phosphorylase kinase regulatory subunit alpha 2 |
D: 1
|
| PHKB | phosphorylase kinase regulatory subunit beta |
D: 1
|
| PHKG1 | phosphorylase kinase gamma 1 |
U: 1
|
| PHKG2 | phosphorylase kinase, gamma 2 (testis) |
U: 1
|
| PI4K2A | phosphatidylinositol 4-kinase type 2 alpha |
U: 1
|
| PI4K2B | phosphatidylinositol 4-kinase type 2 beta |
U: 1
D: 1
|
| PI4KA | phosphatidylinositol 4-kinase alpha |
U: 2
|
| PI4KAP1 | phosphatidylinositol 4-kinase alpha pseudogene 1 |
D: 1
|
| PI4KB | phosphatidylinositol 4-kinase beta |
U: 2
|
| PIBF1 | progesterone immunomodulatory binding factor 1 |
U: 1
|
| PIFO | primary cilia formation |
U: 2
|
| PIH1D1 | PIH1 domain containing 1 |
D: 1
|
| PIK3C2A | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha |
U: 1
D: 2
|
| PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta |
U: 1
D: 1
|
| PIK3C3 | phosphatidylinositol 3-kinase catalytic subunit type 3 |
U: 2
D: 1
|
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
U: 5
D: 5
|
| PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
U: 2
|
| PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
U: 2
D: 2
|
| PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
U: 2
D: 3
|
| PIK3IP1 | phosphoinositide-3-kinase interacting protein 1 |
U: 4
|
| PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
U: 1
|
| PIK3R3 | phosphoinositide-3-kinase regulatory subunit 3 |
U: 2
|
| PIK3R5 | phosphoinositide-3-kinase regulatory subunit 5 |
U: 1
D: 1
|
| PILRB | paired immunoglobin like type 2 receptor beta |
U: 2
|
| PIM1 | proviral integration site 1 |
U: 7
D: 2
|
| PIM2 | proviral integration site 2 |
U: 1
|
| PIM3 | proviral integration site 3 |
U: 2
|
| PINK1 | PTEN induced putative kinase 1 |
U: 3
D: 6
|
| PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
D: 1
|
| PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase, type II, gamma |
U: 1
D: 1
|
| PIP5K1B | phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
U: 1
|
| PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma |
U: 1
|
| PKD1 | polycystin 1, transient receptor poteintial channel interacting |
U: 1
|
| PKDCC | protein kinase domain containing, cytoplasmic |
D: 1
|
| PKIA | protein kinase inhibitor, alpha |
U: 1
D: 2
|
| PKIB | protein kinase inhibitor beta, cAMP dependent, testis specific |
U: 2
D: 1
|
| PKIG | protein kinase inhibitor, gamma |
D: 1
|
| PKLR | pyruvate kinase liver and red blood cell |
D: 1
|
| PKM | pyruvate kinase, muscle |
U: 2
D: 1
|
| PKMYT1 | protein kinase, membrane associated tyrosine/threonine 1 |
U: 1
D: 5
|
| PKN1 | protein kinase N1 |
D: 1
|
| PKN2 | protein kinase N2 |
D: 1
|
| PKN3 | protein kinase N3 |
U: 1
D: 2
|
| PLCE1 | phospholipase C, epsilon 1 |
U: 2
D: 1
|
| PLK1 | polo like kinase 1 |
D: 13
|
| PLK2 | polo like kinase 2 |
U: 2
D: 1
|
| PLK3 | polo like kinase 3 |
U: 3
D: 1
|
| PLK4 | polo like kinase 4 |
D: 6
|
| PMS2P11 | PMS1 homolog 2, mismatch repair system component pseudogene 11 |
D: 1
|
| PMVK | phosphomevalonate kinase |
U: 1
|
| PNCK | pregnancy upregulated non-ubiquitously expressed CaM kinase |
U: 2
|
| PNKP | polynucleotide kinase 3'- phosphatase |
U: 1
|
| PPIP5K1 | diphosphoinositol pentakisphosphate kinase 1 |
U: 1
|
| PPIP5K2 | diphosphoinositol pentakisphosphate kinase 2 |
U: 1
|
| PPM1D | protein phosphatase, Mg2+/Mn2+ dependent 1D |
U: 4
D: 5
|
| PPM1E | protein phosphatase 1E (PP2C domain containing) |
U: 1
|
| PPP1R1B | protein phosphatase 1 regulatory inhibitor subunit 1B |
U: 1
D: 1
|
| PPP1R9A | protein phosphatase 1, regulatory subunit 9A |
U: 1
|
| PPP2CA | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
D: 2
|
| PPP2R3C | protein phosphatase 2, regulatory subunit B'', gamma |
D: 1
|
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha |
D: 2
|
| PRAG1 | PEAK1 related kinase activating pseudokinase 1 |
U: 1
D: 1
|
| PRDX3 | peroxiredoxin 3 |
D: 1
|
| PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
U: 9
D: 11
|
| PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
U: 2
D: 4
|
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit |
D: 1
|
| PRKAB2 | protein kinase, AMP-activated, beta 2 non-catalytic subunit |
U: 3
D: 1
|
| PRKACA | protein kinase, cAMP dependent, catalytic, alpha |
U: 1
D: 1
|
| PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
U: 1
D: 1
|
| PRKAG3 | protein kinase, AMP-activated, gamma 3 non-catalytic subunit |
U: 1
|
| PRKAR1A | protein kinase, cAMP dependent regulatory, type I, alpha |
D: 1
|
| PRKAR1B | protein kinase, cAMP dependent regulatory, type I beta |
U: 1
|
| PRKAR2A | protein kinase, cAMP dependent regulatory, type II alpha |
U: 1
D: 2
|
| PRKAR2B | protein kinase, cAMP dependent regulatory, type II beta |
D: 1
|
| PRKCA | protein kinase C, alpha |
U: 3
D: 3
|
| PRKCD | protein kinase C, delta |
U: 7
|
| PRKCH | protein kinase C, eta |
U: 3
D: 2
|
| PRKCI | protein kinase C, iota |
U: 1
D: 2
|
| PRKCQ | protein kinase C, theta |
U: 1
|
| PRKCZ | protein kinase C, zeta |
D: 1
|
| PRKD1 | protein kinase D1 |
U: 2
D: 1
|
| PRKD2 | protein kinase D2 |
U: 1
D: 1
|
| PRKD3 | protein kinase D3 |
D: 2
|
| PRKDC | protein kinase, DNA activated, catalytic polypeptide |
U: 1
D: 4
|
| PRKG1 | protein kinase, cGMP-dependent, type I |
U: 1
|
| PRKG2 | protein kinase, cGMP-dependent, type II |
D: 1
|
| PRKN | parkin RBR E3 ubiquitin protein ligase |
U: 5
D: 1
|
| PRKX | protein kinase, X-linked |
U: 1
D: 1
|
| PRKY | protein kinase Y-linked (pseudogene) |
U: 1
|
| PRLR | prolactin receptor |
U: 1
|
| PRNP | prion protein |
U: 3
D: 1
|
| PROX1 | prospero homeobox 1 |
U: 2
|
| PRPF4B | pre-mRNA processing factor 4B |
D: 1
|
| PRPS1 | phosphoribosyl pyrophosphate synthetase 1 |
D: 1
|
| PRPS2 | phosphoribosyl pyrophosphate synthetase 2 |
U: 1
D: 2
|
| PRPSAP1 | phosphoribosyl pyrophosphate synthetase-associated protein 1 |
U: 1
D: 1
|
| PSKH1 | protein serine kinase H1 |
U: 1
|
| PSRC1 | proline/serine-rich coiled-coil 1 |
D: 5
|
| PTEN | phosphatase and tensin homolog |
U: 6
D: 20
|
| PTK2 | PTK2 protein tyrosine kinase 2 |
U: 1
D: 4
|
| PTK2B | PTK2 protein tyrosine kinase 2 beta |
U: 1
|
| PTK6 | PTK6 protein tyrosine kinase 6 |
D: 1
|
| PTK7 | PTK7 protein tyrosine kinase 7 |
U: 3
D: 2
|
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 |
U: 2
|
| PTPN2 | protein tyrosine phosphatase, non-receptor type 2 |
U: 1
D: 1
|
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
D: 2
|
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 |
D: 2
|
| PTPRB | protein tyrosine phosphatase, receptor type, B |
U: 2
D: 2
|
| PTPRC | protein tyrosine phosphatase, receptor type, C |
U: 2
D: 2
|
| PTPRH | protein tyrosine phosphatase, receptor type, H |
U: 2
|
| PTPRJ | protein tyrosine phosphatase, receptor type, J |
U: 1
D: 2
|
| PTPRO | protein tyrosine phosphatase, receptor type, O |
U: 1
|
| PTPRQ | protein tyrosine phosphatase, receptor type, Q |
D: 1
|
| PTPRT | protein tyrosine phosphatase, receptor type, T |
U: 1
|
| PXK | PX domain containing serine/threonine kinase |
D: 2
|
| PYCARD | PYD and CARD domain containing |
U: 1
|
| PCP4 | Purkinje cell protein 4 |
D: 1
|
| PMP22 | peripheral myelin protein 22 |
U: 2
D: 1
|
| PSEN1 | presenilin 1 |
U: 3
|
| PXN | paxillin |
U: 1
D: 2
|
| RAC2 | Rac family small GTPase 2 |
U: 1
D: 2
|
| RACK1 | receptor for activated C kinase 1 |
D: 1
|
| RAD50 | RAD50 double strand break repair protein |
U: 1
D: 1
|
| RAF1 | v-raf-leukemia viral oncogene 1 |
U: 3
D: 1
|
| RALB | v-ral simian leukemia viral oncogene B |
U: 1
D: 1
|
| RAP1A | RAS-related protein 1a |
U: 2
|
| RAP2B | RAP2B, member of RAS oncogene family |
D: 1
|
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 |
D: 1
|
| RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 |
U: 1
D: 2
|
| RB1 | RB transcriptional corepressor 1 |
U: 37
D: 7
|
| RBL1 | RB transcriptional corepressor like 1 |
U: 2
D: 3
|
| RBL2 | RB transcriptional corepressor like 2 |
U: 5
|
| RELN | reelin |
D: 1
|
| RFK | riboflavin kinase |
U: 1
|
| RGCC | regulator of cell cycle |
U: 1
D: 4
|
| RGN | regucalcin |
U: 2
D: 6
|
| RGS2 | regulator of G-protein signaling 2 |
D: 3
|
| RHOA | ras homolog family member A |
U: 3
|
| RHOH | ras homolog family member H |
U: 1
|
| RIOK3 | RIO kinase 3 |
U: 1
|
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
U: 1
|
| RIPK2 | receptor (TNFRSF)-interacting serine-threonine kinase 2 |
U: 1
D: 1
|
| RIPK4 | receptor-interacting serine-threonine kinase 4 |
U: 2
|
| RNASEL | ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
U: 3
D: 1
|
| ROBO1 | roundabout guidance receptor 1 |
D: 2
|
| ROCK1 | Rho-associated coiled-coil containing protein kinase 1 |
D: 1
|
| ROCK2 | Rho-associated coiled-coil containing protein kinase 2 |
D: 2
|
| ROR1 | receptor tyrosine kinase-like orphan receptor 1 |
U: 1
D: 1
|
| ROR2 | receptor tyrosine kinase-like orphan receptor 2 |
U: 1
D: 1
|
| ROS1 | Ros1 proto-oncogene |
U: 1
|
| RPLP1 | ribosomal protein lateral stalk subunit P1 |
U: 2
D: 3
|
| RPS3 | ribosomal protein S3 |
D: 1
|
| RPS6KA1 | ribosomal protein S6 kinase polypeptide 1 |
U: 2
|
| RPS6KA2 | ribosomal protein S6 kinase, polypeptide 2 |
U: 1
D: 2
|
| RPS6KA3 | ribosomal protein S6 kinase polypeptide 3 |
U: 1
|
| RPS6KA5 | ribosomal protein S6 kinase, polypeptide 5 |
U: 2
D: 2
|
| RPS6KA6 | ribosomal protein S6 kinase polypeptide 6 |
U: 4
|
| RPS6KB1 | ribosomal protein S6 kinase, polypeptide 1 |
U: 11
D: 4
|
| RPS6KC1 | ribosomal protein S6 kinase polypeptide 1 |
U: 1
|
| RPS6KL1 | ribosomal protein S6 kinase-like 1 |
U: 1
|
| RUBCN | RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein |
U: 1
|
| RAC1 | Rac family small GTPase 1 |
U: 5
D: 3
|
| SASH1 | SAM and SH3 domain containing 1 |
U: 1
D: 1
|
| SBK1 | SH3-binding kinase 1 |
U: 1
D: 2
|
| SDC4 | syndecan 4 |
U: 2
|
| SEPHS1 | selenophosphate synthetase 1 |
D: 2
|
| SEPHS2 | selenophosphate synthetase 2 |
U: 1
|
| SERPINB3 | serpin family B member 3 |
U: 1
|
| SERTAD1 | SERTA domain containing 1 |
U: 1
|
| SESN2 | sestrin 2 |
U: 2
D: 1
|
| SFN | stratifin |
U: 1
|
| SFRP1 | secreted frizzled-related protein 1 |
U: 2
D: 1
|
| SFRP2 | secreted frizzled-related protein 2 |
U: 2
D: 2
|
| SGK1 | serum/glucocorticoid regulated kinase 1 |
U: 3
D: 5
|
| SGK2 | serum/glucocorticoid regulated kinase 2 |
U: 1
|
| SGK3 | serum/glucocorticoid regulated kinase 3 |
D: 1
|
| SGMS1 | sphingomyelin synthase 1 |
U: 1
D: 1
|
| SH2B3 | SH2B adaptor protein 3 |
D: 1
|
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) |
U: 1
|
| SH3BP5L | SH3 binding domain protein 5 like |
U: 2
|
| SIK1 | salt inducible kinase 1 |
U: 2
|
| SIK2 | salt inducible kinase 2 |
U: 1
D: 2
|
| SIRT1 | sirtuin 1 |
U: 12
D: 110
|
| SLAMF8 | SLAM family member 8 |
U: 2
D: 1
|
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
U: 1
|
| SLC8A1 | solute carrier family 8 (sodium/calcium exchanger), member 1 |
U: 1
D: 2
|
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 |
U: 2
D: 1
|
| SLK | STE20-like kinase |
U: 1
|
| SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 homolog (human) |
U: 1
|
| SMG1 | SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) |
D: 3
|
| SMG8 | smg-8 homolog, nonsense mediated mRNA decay factor (C. elegans) |
U: 1
|
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal |
U: 2
|
| SMYD3 | SET and MYND domain containing 3 |
U: 3
|
| SNCA | synuclein, alpha |
U: 3
|
| SNF8 | SNF8 subunit of ESCRT-II |
D: 1
|
| SNRK | SNF related kinase |
U: 1
|
| SNX9 | sorting nexin 9 |
U: 1
|
| SOCS1 | suppressor of cytokine signaling 1 |
U: 4
|
| SOCS2 | suppressor of cytokine signaling 2 |
U: 2
D: 1
|
| SOCS3 | suppressor of cytokine signaling 3 |
U: 1
D: 5
|
| SOCS4 | suppressor of cytokine signaling 4 |
U: 1
D: 1
|
| SOCS6 | suppressor of cytokine signaling 6 |
D: 1
|
| SOCS7 | suppressor of cytokine signaling 7 |
U: 1
|
| SOD1 | superoxide dismutase 1, soluble |
U: 5
D: 4
|
| SORL1 | sortilin-related receptor, LDLR class A repeats-containing |
D: 3
|
| SPATC1L | spermatogenesis and centriole associated 1 like |
D: 2
|
| SPEG | SPEG complex locus |
U: 2
D: 1
|
| SPHK1 | sphingosine kinase 1 |
U: 3
D: 2
|
| SPHK2 | sphingosine kinase 2 |
D: 1
|
| SPRED1 | sprouty protein with EVH-1 domain 1, related sequence |
U: 1
D: 3
|
| SPRY1 | sprouty RTK signaling antagonist 1 |
U: 2
D: 4
|
| SPRY2 | sprouty RTK signaling antagonist 2 |
D: 4
|
| SPRY4 | sprouty RTK signaling antagonist 4 |
D: 2
|
| SQSTM1 | sequestosome 1 |
U: 15
D: 4
|
| SRC | Rous sarcoma oncogene |
U: 2
D: 6
|
| SRCIN1 | SRC kinase signaling inhibitor 1 |
U: 1
D: 1
|
| SRPK1 | serine/arginine-rich protein specific kinase 1 |
D: 1
|
| SRPK2 | serine/arginine-rich protein specific kinase 2 |
U: 1
|
| SRPK3 | serine/arginine-rich protein specific kinase 3 |
U: 1
|
| STK10 | serine/threonine kinase 10 |
U: 2
|
| STK11 | serine/threonine kinase 11 |
U: 5
D: 1
|
| STK17A | serine/threonine kinase 17a |
D: 1
|
| STK17B | serine/threonine kinase 17b (apoptosis-inducing) |
D: 1
|
| STK24 | serine/threonine kinase 24 |
U: 1
D: 3
|
| STK25 | serine/threonine kinase 25 (yeast) |
U: 1
|
| STK31 | serine threonine kinase 31 |
D: 1
|
| STK32A | serine/threonine kinase 32A |
D: 1
|
| STK32B | serine/threonine kinase 32B |
D: 1
|
| STK32C | serine/threonine kinase 32C |
U: 2
|
| STK33 | serine/threonine kinase 33 |
D: 2
|
| STK36 | serine/threonine kinase 36 |
U: 1
D: 1
|
| STK38 | serine/threonine kinase 38 |
U: 1
D: 1
|
| STK38L | serine/threonine kinase 38 like |
U: 2
|
| STK39 | serine/threonine kinase 39 |
D: 2
|
| STK4 | serine/threonine kinase 4 |
U: 1
D: 1
|
| STK40 | serine/threonine kinase 40 |
U: 1
D: 1
|
| STOX1 | storkhead box 1 |
U: 1
D: 1
|
| STRADB | STE20-related kinase adaptor beta |
D: 1
|
| STYK1 | serine/threonine/tyrosine kinase 1 |
U: 1
|
| SYAP1 | synapse associated protein 1 |
U: 1
|
| SYK | spleen tyrosine kinase |
U: 3
D: 2
|
| SH3GLB1 | SH3-domain GRB2-like B1 (endophilin) |
U: 1
|
| SHB | src homology 2 domain-containing transforming protein B |
U: 1
D: 3
|
| STIL | Scl/Tal1 interrupting locus |
D: 5
|
| SYNPO2 | synaptopodin 2 |
U: 2
|
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
D: 1
|
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
U: 1
|
| TAF7 | TATA-box binding protein associated factor 7 |
U: 1
|
| TAL1 | T cell acute lymphocytic leukemia 1 |
U: 1
D: 1
|
| TAOK1 | TAO kinase 1 |
U: 2
|
| TAOK2 | TAO kinase 2 |
U: 2
|
| TAOK3 | TAO kinase 3 |
D: 1
|
| TARBP2 | TARBP2 subunit of RISC loading complex |
D: 1
|
| TBCK | TBC1 domain containing kinase |
D: 1
|
| TBK1 | TANK-binding kinase 1 |
U: 2
|
| TEK | TEK receptor tyrosine kinase |
D: 3
|
| TELO2 | telomere maintenance 2 |
D: 1
|
| TENM1 | teneurin transmembrane protein 1 |
U: 1
D: 1
|
| TESC | tescalcin |
D: 1
|
| TESK2 | testis-specific kinase 2 |
U: 2
|
| TEX14 | testis expressed gene 14 |
U: 1
|
| TF | transferrin |
U: 1
|
| TFAP4 | transcription factor AP4 |
D: 3
|
| TGFB1 | transforming growth factor, beta 1 |
U: 49
D: 6
|
| TGFB2 | transforming growth factor, beta 2 |
U: 5
D: 1
|
| TGFBR1 | transforming growth factor, beta receptor I |
U: 5
|
| TGFBR2 | transforming growth factor, beta receptor II |
U: 4
D: 2
|
| THY1 | thymus cell antigen 1, theta |
U: 2
D: 1
|
| TIAM1 | T cell lymphoma invasion and metastasis 1 |
U: 3
D: 1
|
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
U: 2
|
| TIGAR | Trp53 induced glycolysis regulatory phosphatase |
U: 2
|
| TJP2 | tight junction protein 2 |
D: 2
|
| TK1 | thymidine kinase 1 |
U: 1
D: 6
|
| TK2 | thymidine kinase 2, mitochondrial |
U: 1
|
| TLK2 | tousled-like kinase 2 (Arabidopsis) |
U: 1
|
| TLR3 | toll like receptor 3 |
U: 4
D: 1
|
| TLR6 | toll-like receptor 6 |
U: 1
D: 1
|
| TLR9 | toll-like receptor 9 |
U: 1
D: 1
|
| TNF | tumor necrosis factor |
U: 48
D: 7
|
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
U: 3
D: 1
|
| TNFAIP8L3 | tumor necrosis factor, alpha-induced protein 8-like 3 |
U: 4
|
| TNFRSF10A | TNF receptor superfamily member 10a |
U: 1
D: 1
|
| TNFRSF10B | TNF receptor superfamily member 10b |
U: 3
D: 1
|
| TNFRSF11A | tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
U: 1
D: 1
|
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 |
U: 5
|
| TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 |
U: 4
D: 1
|
| TNIK | TRAF2 and NCK interacting kinase |
U: 1
|
| TOM1L1 | target of myb1-like 1 (chicken) |
D: 1
|
| TOP1 | topoisomerase (DNA) I |
U: 2
D: 1
|
| TPD52L1 | tumor protein D52-like 1 |
U: 1
D: 3
|
| TPK1 | thiamine pyrophosphokinase |
U: 3
|
| TPX2 | TPX2, microtubule-associated |
D: 7
|
| TRAF4 | TNF receptor associated factor 4 |
U: 1
|
| TRAF6 | TNF receptor-associated factor 6 |
U: 1
D: 3
|
| TRIB1 | tribbles pseudokinase 1 |
U: 3
D: 2
|
| TRIB2 | tribbles pseudokinase 2 |
D: 3
|
| TRIB3 | tribbles pseudokinase 3 |
U: 3
D: 2
|
| TRIM24 | tripartite motif-containing 24 |
D: 2
|
| TRIM27 | tripartite motif-containing 27 |
D: 1
|
| TRIM28 | tripartite motif-containing 28 |
U: 2
D: 1
|
| TRIO | triple functional domain (PTPRF interacting) |
U: 1
D: 2
|
| TRPM7 | transient receptor potential cation channel, subfamily M, member 7 |
D: 1
|
| TRRAP | transformation/transcription domain associated protein |
U: 1
D: 1
|
| TSC1 | TSC complex subunit 1 |
U: 1
|
| TSC2 | TSC complex subunit 2 |
U: 1
D: 2
|
| TSG101 | tumor susceptibility gene 101 |
U: 2
D: 1
|
| TSPYL2 | TSPY-like 2 |
U: 4
|
| TSSK3 | testis-specific serine kinase 3 |
U: 1
D: 1
|
| TSSK4 | testis-specific serine kinase 4 |
D: 1
|
| TSSK6 | testis-specific serine kinase 6 |
U: 1
|
| TTBK1 | tau tubulin kinase 1 |
D: 1
|
| TTK | Ttk protein kinase |
D: 6
|
| TTN | titin |
U: 2
D: 3
|
| TWF1 | twinfilin actin binding protein 1 |
U: 1
|
| TYK2 | tyrosine kinase 2 |
U: 1
|
| TYRO3 | TYRO3 protein tyrosine kinase 3 |
U: 1
D: 2
|
| TCF3 | transcription factor 3 |
U: 1
D: 1
|
| TEAD1 | TEA domain family member 1 |
U: 1
D: 1
|
| TLR1 | toll-like receptor 1 |
U: 2
|
| TLR4 | toll-like receptor 4 |
U: 7
D: 2
|
| TNXB | tenascin XB |
U: 1
D: 1
|
| TRP73 | transformation related protein 73 |
D: 3
|
| UBASH3B | ubiquitin associated and SH3 domain containing, B |
D: 2
|
| UCHL1 | ubiquitin carboxy-terminal hydrolase L1 |
U: 1
|
| UCK2 | uridine-cytidine kinase 2 |
U: 1
D: 3
|
| UHMK1 | U2AF homology motif (UHM) kinase 1 |
U: 1
|
| ULK1 | unc-51 like kinase 1 |
U: 2
|
| ULK2 | unc-51 like kinase 2 |
U: 1
|
| ULK3 | unc-51-like kinase 3 |
U: 2
D: 1
|
| UVRAG | UV radiation resistance associated gene |
U: 2
|
| VAC14 | Vac14 homolog (S. cerevisiae) |
U: 1
|
| VANGL2 | VANGL planar cell polarity 2 |
U: 1
|
| VAV3 | vav 3 oncogene |
U: 3
D: 2
|
| VEGFA | vascular endothelial growth factor A |
U: 10
D: 5
|
| VEGFC | vascular endothelial growth factor C |
D: 1
|
| VLDLR | very low density lipoprotein receptor |
U: 2
D: 2
|
| VRK1 | vaccinia related kinase 1 |
D: 3
|
| VRK2 | vaccinia related kinase 2 |
D: 1
|
| WDR81 | WD repeat domain 81 |
U: 2
|
| WDR91 | WD repeat domain 91 |
U: 1
|
| WNK1 | WNK lysine deficient protein kinase 1 |
U: 2
|
| WNK2 | WNK lysine deficient protein kinase 2 |
U: 1
|
| WNK3 | WNK lysine deficient protein kinase 3 |
D: 3
|
| WNK4 | WNK lysine deficient protein kinase 4 |
U: 1
|
| WNT11 | Wnt family member 11 |
U: 1
|
| WNT3A | wingless-type MMTV integration site family, member 3A |
U: 2
|
| WNT5A | wingless-type MMTV integration site family, member 5A |
U: 4
|
| WNT7B | wingless-type MMTV integration site family, member 7B |
U: 3
D: 3
|
| WWTR1 | WW domain containing transcription regulator 1 |
D: 4
|
| WARS | tryptophanyl-tRNA synthetase |
U: 3
D: 2
|
| XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 |
U: 1
D: 7
|
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 |
U: 1
D: 3
|
| YES1 | YES proto-oncogene 1, Src family tyrosine kinase |
U: 1
D: 1
|
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma |
U: 1
|
| ZEB2 | zinc finger E-box binding homeobox 2 |
U: 2
D: 3
|
| ZFP91 | zinc finger protein 91 |
U: 1
|
| ZNF16 | zinc finger protein 16 |
D: 1
|
| ZNF622 | zinc finger protein 622 |
U: 1
|
| ZNF675 | zinc finger protein 675 |
D: 1
|